Senator Tillis Letter to FDA and USPTO Asking for a Study of Relationship between Patents and Drug Prices

In a January 31, 2022 letter to Drew Hirshfeld, the Commissioner for Patents for the USPTO, and Janet Woodcock, the Acting Commissioner of the FDA, Senator Thom Tillis provides extensive criticism of the empirical work of the group I-MAK and… Continue Reading

Obama officials seek end of WIPO program on limitations and exceptions to patent rights in developing countries

During the WIPO 2014 General Assembly’s discussions of patents and health in the context of the work of the Standing Committee on the Law of Patent (SCP), the Obama Administration embraced an aggressive position against WIPO technical assistance on the use of patent limitations and exceptions.

Continue Reading

© 2022 Knowledge Ecology International. All rights reserved.
Hiero by aThemes